QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced plans to advance its QuantiFERON latent tuberculosis (TB) test with a new fully automated Sample to Insight workflow and a ...

Artificial intelligence (AI) tools that identify pathologic features from digitized whole-slide images (WSIs) of prostate cancer (CaP) generate data to predict outcomes. The objective of this study ...

In the last decade, software engineering has undergone a rapid transformation driven by cloud computing, DevOps, big data, and continuous delivery. Yet among all these advancements, one force stands ...

With early detection of prostate cancer recognised as a critical part in reducing the disease’s mortality rate, PanGIA Biotech has shared results from a study validating its artificial intelligence ...

We’re at the beginning of a new era in quality engineering, one shaped by agentic AI. While generative AI has captured global attention, the real transformation in software testing is only just ...

Developing an LLM testing strategy is challenging because the model’s inputs are open-ended and responses are non-deterministic. AI agents couple language models with the ability to take ...

Please provide your email address to receive an email when new articles are posted on . The FDA announced plans in 2025 to reduce animal testing requirements in biomedical research. New approach ...

The limbo between having blood drawn and receiving the results can be stressful for patients. Then the jargon-filled blood test report arrives before a doctor can review it and translate the findings.